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This review aims to present the potential information related to 
pharmacological actions and chemical composition of Gymnema sylvestre 
R.Br. (Asclepiadaceae), which is used in many Asian countries as a 
traditional medicine especially for the treatment of diabetes mellitus. Our 
main objective was to collect information about pharmacological actions 
and active constituents of this plant. Review of literature included PubMed, 
Science Direct searches with ‘Gymnema sylvestre’ and ‘gurmar’ as initial 
key words. The search was further refined by looking for terms such as 
‘Constituents’ (or composition) and ‘Activity’ (or effect) within the results. 
The major bioactive constituents of G. sylvestre are a group of triterpenoid 
glycosides known as gymnemic acids with gymnemagenin as common 
aglycone. G. sylvestre has good prospects in the treatment of diabetes as it 
shows positive effects on blood sugar homeostasis, controls sugar cravings, 
and promotes regeneration of pancreas. The herbal extract is used in 
dietary supplements because it reduces body weight, blood cholesterol, and 
triglyceride levels.  The G. sylvestre is a rich source of chemically novel 
compounds and needs elaborate screening strategies to dwell into the 
pharmacological effects of its phyto-constituents at the molecular level. 
 
INTRODUCTION
This review aims to present the 
potential information related to 
pharmacological actions and chemical 
composition of Gymnema sylvestre R.Br. 
(Asclepiadaceae), which is used in many 
Asian countries as a traditional medicine 
especially for the treatment of diabetes 
mellitus. Review of literature included 
PubMed, Science Direct searches with 
‘Gymnema sylvestre’ and ‘gurmar’ as 
initial key words. The search was further 
refined by looking for terms such as 
‘Constituents’ (or composition) and 
‘Activity’ (or effect) within the results. 
The major bioactive constituents of G. 
sylvestre are a group of triterpenoid 
glycosides known as gymnemic acids with 
gymnemagenin as common aglycone. G. 
sylvestre has good prospects in the 
treatment of diabetes as it shows positive 
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effects on blood sugar homeostasis, 
controls sugar cravings, and promotes 
regeneration of pancreas. The herbal 
extract is used in dietary supplements since 
it reduces body weight, blood cholesterol, 
and triglyceride levels and holds great 
prospects in dietary as well as 
pharmacological applications.   
Gymnema sylvestre R.Br. 
(Asclepiadaceae) is a herb native to the 
tropical forests of southern and central 
India and Sri Lanka. Chewing the leaves 
suppresses the sensation of sweet taste. It 
has been used as traditional medicine for 
the treatment of diabetes.[9]  Sushruta 
describes G. sylvester, as a destroyer of 
madhumeha (glycosuria) and other urinary 
disorders. The plant is also used as bitter, 
astringent, acrid, thermogenic, anti-
inflammatory, anodyne, digestive, liver 
tonic, emetic, diuretic, stomachic, 
stimulant, anthelmenthics, laxative, 
cardiotonic, expectorant, antipyretic and 
uterine tonic. It is useful in dyspepsia, 
constipation, jaundice, haemorrhoids, renal 
and vesical calculi, cardiopathy, asthma, 
bronchitis, amenorrhoea, conjuctivitis and 
leucoderma.[10]  However, to best of our 
knowledge, till date systemic studies to 
understand the molecular basis of diabetes 
and related complications preventing 
properties of active constituent of G. 
sylvestre (gymnemic acids) has not been 
reported. Hence, the present review aims 
to compile an up-to-date information on 
the progress made in the protective role of 
G. sylvestre and or gymnemic acids in 
diabetes mellitus and related complications 
with the objective of providing a guide for 
future research on this plant and bioactive 
molecule. Hence, we planned to collect the 
research articles related to G. sylvestre and 
gymnemic acids from various scientific 
databases and write a systemic review of 
its potential pharmacological role in 
management of diabetes mellitus and 
related cardiovascular complications. The 
review papers also enlisted phytochemistry 





The information on the G. sylvestre and 
gymnemic acids in diabetes mellitus and 
related complications were collected from 
several databases such as Science direct, 
Pubmed, NCBI, Springer and Google 
scholar etc., from 1962 to 2018. Some 
information also collected from the official 
websites, such as IDF, and WHO. The 
keywords used for the searching, such as 
G. sylvestre and diabetes mellitus, G. 
sylvestre and antihyperlipidaemic activity, 
G. sylvestre and antioxidant activity, G. 
sylvestre and anti-inflammatory activity, 
and analytical reports and 
pharmacokinetics of gymnemic acids. 
 
PHYTOCHEMICAL REPORTS  
The major bioactive constituents of G. 
sylvestre are a group of oleanane type 
triterpenoid saponins known as gymnemic 
acids. The chemical structures of 
phytoconstituents isolated from G. 
sylvestre are summarized in Figure 1. 
Triterpenoid saponins of gymnemic acid 
A, B, C and D with sugar residues such as 
glucuronic acid, galacturonic acid, ferulic 
and angelic acids attached through 
carboxylic acids. The leaves also contain 
betaine, choline, gymnamine alkaloids, 
inositol and 1-quercitol.[11]   
Hydrocarbons such as nonacosane, 
hentriacontane, tritriacontane, 
pentatriacontane, phytin, resin, tartaric 
acid, formic acid, butyric acid, amino acids 
such as leucine, isoleucine, valine, alanine, 
γ-butyric acid has been reported.[12] 
Gymnestrogenin, a pentahydroxy 
triterpene from the leaves of G. sylvestre 
has been reported.[13]   
Four tritepenoid saponins, gymnemasins 
A, B, C and D isolated from the leaves of 













respectively. The aglycone, gymnemanol, 
is characterized as 3β,16β,22α,23,28-
pentahydroxyolean-12-ene.[14]   
The gymnemic acids reported from G. 
sylvestre includes gymnemic acids I-VII, 
gymnemosides A-F and 
gymnemasaponins.[15-16]   
Six triterpene glycosides are isolated from 
the dried leaves of G. sylvestre and 
characterized as gymnemosides a, b, c, d, 
e, and f. The structures of gymnemosides a 
and b are determined as 21-O-tigloyl-22-
O-acetylgymnemagenin 3-O-β-D-
glucopyranosiduronic acid and 16-O-
acetyl-21-O-tigloylgymnemagenin 3-O-β-
D-glucopyranosiduronic acid, 
respectively.[17]   
Six oleanane-type saponins were isolated 
from the leaves of G. sylvestre. The 
structures of the oleanane triterpene 






glucopyranosyl oleanolic acid 28-O-β-D-





glucopyranosyl oleanolic acid 28-O-β-D-
glucopyranosyl ester and 3-O-β-D-
glucopyranosyl (1→6)-β-D-
glucopyranosyl oleanolic acid 28-β-D-
glucopyranosyl (1→6)-β-D-
glucopyranosyl ester.[18]   
Wen-Caiet al.,[19]   isolated five triterpenes 
from the leaves of G. sylvestre namely30-






A flavonol glycosides, kaempferol 3-O-β-
D-glucopyranosyl-(1→4)-α-L-
rhamnopyranosyl-(1→6)-β-D-
galactopyranoside have been isolated from 
the aerial parts of G. sylvestre.[20]   
Two oleanane-type triterpenoid saponins, 
gymnemoside-W1 and W2 were isolated 
from the leaves of G. sylvestre, and 






Eight compounds are isolated from stem of 
G. sylvestre; conduritol A, 1-heptadecanol, 
stigmasterol glucoside, 1-quercitol, 1-
octadecanol, potassium nitrate, 
lupeolcinnamate and stigmasterol.[22]Few 
workers also isolated different chemical 
constituents from G. sylvestre mention in 
Figure 1.[23-26] 
A mixture of gymnemicacids was 
precipitated from the water extract of 
leaves of G. sylvestre by acidification with 
mineral acid. The chromatographic 
separation of gymnemic acids mixture 






28-O-β-D-glucopyranosyl ester (2); 3-β-O-
D-glucopyranosyl21-O-hydrocinnamoyl-
16β,21β,23,29-tetrahydroxyoleanolic acid 
28-Oβ-D-glucopyranosyl ester (3) and 3-
O-β-D-glucuronopyranosyl-21-O-
hydrocinnamoyl-7β-
hydroxygymnemagenin (4) along with a 




Gymnema sylvestre has a long history of 
human use in traditional medicine 
throughout the world. There is plethora of 
reports of experimental and clinical 
evidences related to its different uses that 
are summarized below (also in Table 1). 




Antidiabetic and Hypolipidaemic activity 
The ethanol extract of G. sylvestre at a 
dosage of 100 mg/kg orally was evaluated 
for its antidiabetic effects in normal and 
anterior pituitary extract induced 
hyperglycaemic rats. The results indicated 
insignificant reduction in blood sugar in 
normal rats, whereas significant reduction 
in anterior pituitary extract induced 
hyperglycaemic rats.[28-29] 
G. sylvestre extracts and purified 
gymnemic acid showed inhibitory effects 
on Gastic Inhibitory Peptide (GIP) release 
in rats, the results suggested that a glucose 
receptor which interacted with the leaf 
extracts of G. sylvestre and purified 
gymnemic acid.[30] Gymnemoside b and 
gymnemic acids III, V, and VII showed a 
little inhibitory activity against glucose 
absorption, but the principal constituents, 
gymnemic acid I and gymnemasaponin V 
lack this activity in oral glucose-loaded 
rats.[31] 
The alcoholic extract of G. sylvestre 
stimulated insulin release from HIT-T15, 
MIN6 and RINm5F β-cells and from islets 
in the absence of any other stimulus, and 
G. sylvestre stimulated insulin secretion 
was attributed to increased membrane 
permeability.[32] 
Sugihara et al.[33]examined the 
antihyperglycemic action of a crude 
saponin fraction and five triterpenic 
glycosides (gymnemic acids I-IV and 
gymnemasaponin V) derived from the 
methanol extract of leaves of G. sylvestre 
in STZ-induced diabetic mice. The saponin 
fraction (60 mg/kg) reduced blood glucose 
levels 24 h after i.p. administration. 
Gymnemic acid IV significantly reduced 
the BGL after the administration 
comparable to glibenclamide, and did not 
change the BGL of normal mice.  
G. sylvestre extract treatment once a day to 
rats fed with high fat diet or normal fat diet 
for 3 weeks, improved serum cholesterol 
and triglyceride levels through the 
influence over a wide range of lipid 
metabolism.[34] 
G. sylvestre extract suppressed body 
weight gain and accumulation of liver 
lipids in high fat diet induced experimental 
diabetes whereas in normal fat diet, plasma 
triglyceride levels decreased.[35]The 
ethanolic extract of G. sylvestre leaf was 
examined in-vitro and in-vivo to 
investigate the hypoglycemic and 
antioxidants effects in diabetic rats. The 
extract exhibited strong antioxidant 
activity in the assays, including TBA 
(56%), SOD-like (92%), and ABTS 
(54%). Blood glucose levels in the diabetic 
rats fed G. sylvestre extract decreased to 
normal levels.[36] Methanolic extract of G. 
sylvestre and Andrographis paniculata 
was administered orally in graded doses of 
30 mg/kg,50mg/kg Sprague dawly rats. G. 
sylvestr eand A. paniculata showed 
significant anti-hyperglycemic and anti-
oxidative effect at a dose of 30mg/kg and 
50mg/kg, respectively which was evident 
from the 1st week of treatment.[37] 
The arylated compounds (1–4) showed 
dose dependent inhibition ofα-glucosidase 
that was found to be comparable to 
acarbose. The results revealed that the 
overall pattern of acyl and or aryl 
substitution and glycosylation of 
compounds affected their inhibitory 
activity. The bidesmosidic glycosides (2 
and 3) showed improved potency than the 
monodesmosidic glycosides (1 and 4) 
possibly because the additional glucose 
unit in the former facilitated stronger 
hydrogen bonding at the catalyticsite. The 
current study provides relatively direct 
evidence of effectiveness of G. sylvestre 
against hyperglycemia.[27]The antidiabetic 
studies of G. sylvestre were also evaluated 
by several other workers.[38-47]The clinical 
studies on G. sylvestre were also reported 
by many workers.[48-50] 
Leaf extract of G. sylvestre (25-100 mg/kg 
p.o.) administered to high fat fed 
hyperlipidaemic rats for two weeks 
reduced the elevated serum triglycerides, 
total cholesterol, VLDL and LDL-
cholesterol in a dose dependent manner. Its 
anti-antheroscelrotic potential were almost 




similar to that of a standard lipid lowering 
agent clifibrate.[51]The aqueous leaf extract 
ofG. sylvestre in alloxan induced diabetic 
ratsat the dose of 400, 600 and 800 mg/kg 
were evaluated for 30 days. The fasting 
blood glucose, cholesterol and serum 
triglyceride content were found to be 
significantly reduced (p<0.05) in treated 
rats whereas the extract also showed the 
potent elevation in the level of serum HDL 
cholesterol.[52] 
In the study, highcholesterol diet, standard 
atorvastatin, and high cholesterol diet with 
hydro-alcoholic extract of gymnemic acid 
were fed to female rats for seven days. It 
was observed that the rats fed with high 
cholesterol diet showed increase in serum 
cholesterol, serum triglycerides, low-




tonormal animals. The group administered 
with hydro-alcoholic extract of Gymnema 
leaves at a dose of 200mg/kg showed 
significant reduction in the levels of all 
lipids with increase in HDL-C as 
compared to high cholesterol diet 
control.[53] 
A study demonstrated that the hexane 
extract of the leaves of G. 
sylvestrepossessesantiobesityactivity.Itwas
foundthat,after45daysofadministration of 
hexane extract of G. sylvestre, a significant 
reduction in increased body weight and 
high temperature due to obesity 
wasobserved.Also,thehexaneextractimprov
edthecholesterol,triglyceride,LDL,andHD
Llevels.Thehexaneextractof the leaves of 
G. sylvestre have the potential to treat 
obesity comparable with that of standard 
drug, atorvastatin.[54] The studies showed 
that the leaf extract has good prospects in 
the reduction of cholesterol levels and as a 
herbal medication for obesity. 
Antimicrobial activity  
In an in-vitro study, the ethanolic extract 
of G. sylvestre leaves showed 
antimicrobial activity against Bacillus 
pumilis, B. subtilis, Pseudomonas 
aeruginosa and Staphylococcus aureus 
and inactivity against Proteus vulgaris and 
Escherichia coli.[55] 
The crude extracts of G. sylvestre leaves 
and purified gymnemagenol compound 
were studied against the early fourth-instar 
larvae of Anopheles subpictus and Culex 
quinquefasciatu.[56] 
Hepatoprotective activity 
The alcoholic extract of the G. sylvestre 
leaves at 300 mg/kg p.o. dose showed 
hepatoprotective activity against CCl4-
induced hepatic damage in rats. The 
extract showed a significant decrease in 
weight and volume of liver, levels of 
SGPT and ALP and reduced 
pentobarbitone (50 mg/kg, i.p.) induced 
sleeping time as compared to control 
group.[57] 
Cytotoxic activity  
Gymnemagenol, a saponin isolated from 
the methanolic extract of the leaves at 5, 
15, 25 and 50 µg/ml concentrations 
showed dose-dependent in-vitro cytotoxic 
activity against HeLa (Human cervical 
carcinoma) cells with IC50 value being 37 
µg/ml at 48 h exposure period.[58] 
 
ANALYTICAL REPORTS  
Given the importance of G. sylvestre in 
traditional systems of medicine, only few 
analytical methods have been reported for 
the estimation of its bioactive component 
gymnemic acid as gymnemagenin. An 
HPTLC method has been developed for 
the determination of gymnemagenin in G. 
sylvestre leaves. The gymnemagenin was 
separated on pre-coated silica gel 60 F254 
plates with chloroform-methanol (9:1) and 
scanned using a densitometric scanner in 
the UV reflectance mode at 290 nm.[59] 
HPTLC method has been developed for 
the standardisation of G. sylvestre with 










                Table 1. Pharmacological   and Clinical Activities of G. sylvestre 
S. No. Fraction/ 
Constituents 
Pharmacological activities References 
1 Ethanol extract G. sylvestre at a dosage of 100 mg/kg orally shows 
insignificant reduction in blood sugar in normal rats 
[28-29] 
2 Gymnemosides Gymnemoside b and gymnemic acids III, V, and VII 










The crude saponin fraction and gymnemic acids I-IV 
and gymnemasaponin V showed antidiabetic activity 
in STZ-induced diabetic mice 
[33] 
5 Extract G. sylvestre extract treatment improved serum 









Methanolic extract showed significant anti-




The arylated gymnemic acids showed dose dependent 
inhibition of α-glucosidase enzyme in in-vitro 
[27] 
9 Leaf extract Leaf extract of G. sylvestre showedanti-
antheroscelrotic potential in experimental animal 
model 
[51] 
10 Aqueous leaf 
extract 
The aqueous leaf extract of G. sylvestre showed anti-
hyperlipidemic effects in experimental animal model 
[52] 
11 Hexane extract The hexane extract of the leaves of G. sylvestre 




In an in-vitro study, the ethanolic extract of G. 




The alcoholic extract of the G. sylvestre leaves showed 
hepatoprotective activity against CCl4-induced hepatic 
damage in rats 
[57] 
14 Gymnemagenol Gymnemagenol showed dose-dependent in-vitro 

































I -tga -H -Ac -H 
II -mba -H -Ac -H 
III -mba -H -H -H 
IV -tga -H -H -H 
V -tga -tga -H -H 
VIII -mba -H -H -OG 
IX -tga -H -H -OG 
X -H -H -Ac -H 
XI -tga -H -tga -H 
XII -tga -H -Ac -glu 
XIII -H -H -mba -H 
XIV -H -H -tga -H 
 
(Where: -Ac = acetyl; -Glu = glucose; -OG = β-arabino-2-hexulopyranosyl, tga = tigloyl, mba 
= 2-methyl butyroyl) 
 








































Gymnemasins B (3-O-[β-D-glucopyranosyl (1→3)-β- D-glucuronopyranosyl]-gymnemanol) 



























Gymnemasins D (3-O-β-D-glucuronopyranosyl-gymnemanol) 






























































3-β-O-D-glucopyranosyl 21-O-hydrocinnamoyl-16β,21β,23,29-tetrahydroxyoleanolic acid 





























3-β-O-D-glucopyranosyl 3β, 16β, 23, 28-tetrahydroxyolean-12-ene (5) 

























































































































































































3, β-16, β-22, α-23-28-pentahydroyolean-12ene 








Flavonol glycoside:(Liu et al.[25]) 




















Lupeol     Paraben 











Stigmasterol     D-Quercitol  
(Potawale at al.[26]) 
Figure. 1. Chemical constituents reported from G. sylvestre
The method involves the initial hydrolysis 
of gymnemic acids, the active ingredients, 
to a common aglycone followed by 
quantitative estimation of 
gymnemagenin.[60] 
An HPTLC method has been developed 
for the indirect determination of gymnemic 
acids as gymnemagenin in G. sylvestre. 
The method was found to be more 
sensitive, precise and accurate for 
quantification of gymnemagenin from 
plant leaf powder, extract and poly herbal 
marketed formulation.[61] 
Another RP-HPLC method has been 
developed for the determination of 
gymnemagenin in leaves G. sylvestre. 




Gymnemagenin was obtained after acidic 
hydrolysis followed by basic hydrolysis of 
the sample and extraction into ethyl 
acetate. The developed method was 
applied for the analysis of leaf samples of 
G. sylvestre collected from three different 
regions, a marketed G. sylvestre extract 
and an anti-diabetic polyherbal 
formulation containing G. sylvestre leaf 
powder.[62] An indirect simultaneous 
estimation of gymnemic acid as 
gymnemagenin and charantin as β-
sitosterol after hydrolysis has been 
developed. Aluminum-backed silica gel 60 
F254 plates were used as stationary phase 
and toluene-ethyl acetate-methanol-formic 
acid (60:20:15:5, v/v) as mobile phase. 
Developed chromatogram was scanned at 
550 nm after derivatization with modified 
vanillin–sulfuric acid reagent. The 
developed method was successfully 
applied for the analysis of leaf samples of 
G. sylvestre and fruits of M. charantia and 
herbal formulation containing G. sylvestre, 
M. charantia and Enicostema littorale.[63] 
 
CONCLUSION  
G. sylvestre hold saunique position among 
the sweetness modifying materials of 
natural origin. The herb accounts for 
multiple pharmacological significance as a 
naturopathic medication since ancient 
times and gaining popularity in the present 
scenario as well. Several clinical trials and 
experimental studies indicated that the 
plant is an invaluable source of bioactive 
compounds and phytoconstituents like 
gymnemic acids have been used as 
molecular targets in drug development. 
Besides having pharmacological 
importance, the herbal extract exhibits 
good prospects in dietary applications. 
Amongthemedicinalplants, G. sylvestre is 
a herb less exploited for its innumerable 
advantages. The aim of this review is to 
highlight the prospects of 
thisrareherbasapotentialmedicationfortreat
mentofdiseases from diabetes, obesity to 
cardiovascular disorders. G. sylvestreis a 
rich source of chemically novel 
compounds and needs exhaustive 
screening against new targets in future. 
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